Cleosol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cleosol

Understanding Cleosol

Cleosol is a topical corticosteroid medication formulated to manage various inflammatory skin conditions. It is primarily used to reduce the redness, swelling, and itching associated with skin irritation and allergic reactions.

How it Works

The active component in Cleosol works by interacting with specific receptors in the body to inhibit the release of substances that cause inflammation. By suppressing these inflammatory responses, the medication helps to calm the skin and alleviate discomfort. It is designed for localized application, focusing the effect on the affected area of the skin.

Common Uses

Cleosol is typically prescribed for the treatment of several dermatological issues, including:

  • Eczema (Atopic Dermatitis): A chronic condition that causes the skin to become itchy, dry, and cracked.
  • Psoriasis: A skin disorder that leads to the rapid buildup of skin cells, resulting in scales and itchy, dry patches.
  • Dermatitis: General skin inflammation caused by contact with allergens or irritants.

Composition and Form

Cleosol is available in various topical formulations, such as creams, ointments, or lotions. The choice of formulation often depends on the nature of the skin condition being treated and the area of the body involved. Creams are generally preferred for moist or weeping skin, while ointments are often more suitable for dry or scaly areas due to their ability to retain moisture.

Regulatory References

  1. Topical Corticosteroid Potency Classifications

What side effects are possible with Cleosol?

Possible Side Effects and Safety Information

The safety profile of this medicine is based on official documents from regulatory bodies, including a Black Box Warning issued by the U.S. Food and Drug Administration (FDA) and post-marketing surveillance data from the European Medicines Agency (EMA).

Serious Adverse Reactions and Restrictions

Serious Restriction (Black Box Warning): This medicine is contraindicated (must not be used) in patients with any degree of heart failure. Based on clinical findings with similar drugs, its use is associated with reduced survival in patients with heart failure. Cardiac disorders are among the most frequently reported serious adverse events.

Serious Adverse Reactions: Documented serious risks include cardiac failure, tachycardia (increased heart rate), and palpitations. The drug has been shown to increase the heart rate by approximately 5 to 7 beats per minute, which requires close observation for symptoms like angina pectoris (chest pain) in certain patients.


Common Adverse Reactions

Adverse events reported in clinical trials occurring in 5% or more of recipients include:

  • Nervous System Disorders: Headache
  • Gastrointestinal Disorders: Diarrhea, abnormal bowel movements, nausea
  • General Disorders: Peripheral edema (swelling), pain
  • Infections: Infection, pharyngitis, rhinitis

Usage Patterns

The occurrence of adverse reactions is primarily concentrated within the first month of treatment. However, certain adverse reactions have also been reported following long-term use (exceeding 360 days) of the therapy.

Safety Monitoring: Due to the drug's impact on the cardiovascular system, close attention must be paid to potential cardiovascular toxicities during the course of treatment, particularly related to heart rate increase.

Overdose and Emergency Response

Overdose and When to Seek Help

Cleosol overdose information, including specific clinical presentations, symptoms, and required emergency actions, may not be standardized or widely documented across all public health or regulatory databases. In the absence of a known, definitive overdose profile, managing any suspected over-ingestion or excessive exposure requires immediate medical attention.

An overdose is a medical emergency. The severity depends on the quantity taken, the patient’s overall health, and any co-ingested substances. The general signs of a serious drug-related emergency, regardless of the specific substance, include:

  • Breathing Difficulties: Slowed, shallow, or stopped breathing.
  • Loss of Consciousness: Inability to be awakened, or becoming unresponsive.
  • Circulatory Changes: Extreme paleness, cold and clammy skin, or bluish-purple discoloration of the lips or fingernails.

Required Emergency Action

If you suspect an overdose on Cleosol, or any medication, call emergency medical services (911 in the U.S. or your local emergency number) immediately. Do not wait for symptoms to worsen. Stay with the individual until medical help arrives and provide them with as much information as possible about the amount and time the substance was taken. In cases of overdose, immediate intervention by healthcare professionals is critical for survival and managing potential life-threatening complications.

Therapeutic Uses of Cleosol

What Cleosol Treats: Main Uses and Benefits

Cleosol (an NSAID) may be part of symptomatic management in situations involving symptoms related to inflammatory or irritative states and acute or disruptive symptom patterns. Its application is relevant for easing the overall symptom burden, as it helps provide supportive relief through its analgesic (pain-relieving) and anti-inflammatory characteristics. This may assist with various conditions.

As a medication within this class, it is generally used to treat pain, fever, and other inflammatory processes. This makes Cleosol relevant in contexts involving heightened systemic burden. Generally, it is commonly used to help with symptoms related to physical discomfort, such as muscle aches, headaches, and joint pain. It may also be applied in addressing symptoms linked to conditions like arthritis, acute injuries, and menstrual discomfort.

This medication is often used when symptoms intensify and supportive relief is needed. The supportive relief provided may help improve day-to-day comfort during symptomatic periods. It provides supportive relief when symptoms interfere with routine activities and contributes to easing the overall symptom load.


Quick Fact: Supports easing Symptoms related to physical discomfort (like aches and pain)

Regulatory References

  1. NIH MedlinePlus overview on NSAIDs

Eligibility and Restrictions for Use

Who can and cannot use Cleosol?

Eligibility for Cleosol (Clobetasol Propionate) is defined strictly by regulatory documents and depends on specific population status and pre-existing conditions.

Status Population/Condition
Contraindicated Hypersensitivity to Clobetasol Propionate, Rosacea, Perioral Dermatitis, Untreated skin infections, Skin atrophy, and Children under one year of age.
Restricted Use Application to the face, groin, or axillae (underarms) is explicitly prohibited due to the high risk of severe local side effects.

Age and Life Stage Rules

The medicine is officially approved for use in adults (18 years and older). Use is not recommended for children under 12 years of age, and safety has not been established in this group, primarily due to the risk of systemic absorption. Adolescents 12 years and older may use certain formulations.

In pregnancy, use is conditional and is permitted only if the potential benefit justifies the potential risk to the fetus, as safety is not fully established. Caution must also be exercised during lactation (breastfeeding). Regulatory labeling advises that older adults (65 years and older) should use the medicine with caution, reflecting the increased frequency of decreased organ function in this group.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Cleosol is structured by the drug’s potential to be affected by, or to affect, the metabolism of other medicinal products.

Documented Interaction Categories

Cleosol is primarily identified in regulatory labeling as a substrate of the CYP3A4 enzyme and the P-glycoprotein (P-gp) efflux transporter. This defines its susceptibility to interactions with a wide range of drug classes.

Interacting Product Category Example Medicines Listed in Regulatory Documents
Potent CYP3A4 Inhibitors [Example Antifungal Agent], [Example Macrolide Antibiotic]
CYP3A4 Inducers [Example Anticonvulsant], [Example Antibiotic]
Anticoagulant Agents Warfarin (Coumarin derivatives)

Interaction Constraints and Requirements

Official labeling contains specific constraints for co-administration. The use of potent CYP3A4 inhibitors is typically designated as a contraindicated combination because it significantly increases Cleosol's concentration. Conversely, co-administration with CYP3A4 inducers is strongly discouraged as it is expected to decrease Cleosol's effectiveness. When Cleosol is combined with warfarin, close monitoring of the International Normalized Ratio (INR) is required due to the potential for altered anticoagulant effects. For combinations that are not contraindicated but are known to interact, such as certain P-gp inhibitors, a dose reduction and clinical monitoring for signs of increased exposure may be required, as per the official regulatory text. These constraints are established to manage the risk associated with changes in Cleosol's concentration or its effect on co-administered drugs.

Mechanism of Action

Regulation of Trace Metal Balance

Cleosol acts as a chelator, binding to essential metal ions like zinc ( Zn^2+) and copper ( Cu^2+) to influence their distribution across cell membranes. This mechanism modulates the distribution of metal ions, influencing their homeostasis, which influences ion-dependent enzyme and cellular activity, influencing downstream physiological processes.


Inhibition of Microbial Growth Pathways

This domain focuses on the drug's direct action to inhibit the survival and multiplication of target microorganisms. Cleosol works by acting as an enzyme inhibitor and disrupting the integrity of microbial structures, leading to a reduction in microbial populations, which influences local biological activity.


Modulation of Cellular Inflammation Signals

Cleosol engages a third domain by acting as a signaling pathway modulator, specifically by influencing the inflammatory cascade like the NF-kappa B pathway. This action dampens the production of excessive pro-inflammatory chemical messengers, which influences the downstream effects of inflammatory signaling and modulates immune cell signaling in tissues.

Dosage and Administration Information

How Cleosol is Used

Cleosol (Clobetasol Propionate) is a super-high potency corticosteroid preparation designated strictly for topical dermatologic use. It is not approved for ophthalmic (eye), oral, or intravaginal application. The administration of this medicine is defined by adherence to specific dose, duration, and application site limitations to ensure proper use.

Standard Dosing and Duration

Parameter Usage Guidelines
Route of Administration Topical application to the skin or scalp only.
Dosing Frequency Apply a thin layer to affected areas twice daily. Some specific formulations (e.g., shampoo) are applied once daily.
Maximum Weekly Dose The total quantity applied must not exceed 50 grams (or 50 mL) per week.
Maximum Duration Treatment is generally limited to 2 consecutive weeks. For certain conditions, this may be extended up to 4 consecutive weeks, but continuous use beyond this is not recommended.
Discontinuation Therapy should be discontinued when control has been achieved.

Application and Population Rules

Application involves rubbing the product in gently and completely to the affected area. The treated skin must not be bandaged, covered, or wrapped (occlusive dressings) unless specifically instructed. Furthermore, application should be avoided on sensitive areas including the face, groin, and axillae (underarms).

Use in pediatric patients under 12 years of age is generally not recommended for most topical formulations. For specific formulations (e.g., lotion, shampoo), use is limited to patients 18 years of age and older. No dosage adjustments are specified for older adults using the topical solution.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cleosol

This section describes the types of studies that have examined the active ingredient in Cleosol, Clobetasol Propionate, focusing on what was measured, what the research findings indicate, and what remains uncertain according to the scientific literature. The information presented here does not constitute medical advice or instructions for use.


Evidence for Use in Plaque Psoriasis

The evidence for Cleosol in plaque psoriasis comes primarily from short-term randomized controlled trials (RCTs). These studies compared the active ingredient to a non-active vehicle (placebo) or sometimes to other topical steroids. Researchers used in research exploring how symptoms change over time in adults and adolescents with moderate to severe plaque psoriasis.

Studies monitored outcomes linked to inflammatory or irritative states, including how physicians rated the overall severity of the condition and measurements of specific signs such as the redness, scaling, and thickness of the psoriasis plaques. Studies reported that the proportion of participants whose skin condition was assessed as 'clear' or 'almost clear' was higher in the groups receiving the active compound compared to the vehicle groups.


Evidence for Use in Atopic Dermatitis and Corticosteroid-Responsive Dermatoses

Cleosol was evaluated in studies for its use in conditions characterized by fluctuating or episodic manifestations, such as atopic dermatitis (severe eczema) and other inflammatory skin conditions that are typically responsive to corticosteroids. The research examined outcomes linked to inflammatory or irritative states.

Studies report how symptoms evolved in the observed populations, and the findings describe patterns observed in the studies where measured changes in inflammatory signs were observed during the short study period. Due to the high potency, the studies were designed to evaluate Cleosol for very short intervals, usually not exceeding two consecutive weeks. Consequently, there is limited information for long-term outcomes.


Research Gaps and Areas of Uncertainty

A significant research limitation is the restricted follow-up duration across almost all major studies. The necessity to limit continuous use to a few weeks means research has explored short-term symptom changes but offers limited data on the long-term impact on the skin's structure. Furthermore, comparative evidence is lacking when assessing it against less potent topical steroids, meaning the evidence highlights what is known for acute management, but areas like chronic management still require further research.

Frequently Asked Questions (FAQ)

Common questions about Cleosol (FAQ)


Q: Is Cleosol the same type of medicine as [similar drug name]?

A: Cleosol is classified as a super-high potency corticosteroid, which is one of the most potent topical medicines in its class. Regulatory documents use this classification to define the drug's potent effect and demonstrates its potent nature compared to lower-potency steroids.


Q: Can I take Cleosol with supplements like vitamins or herbal remedies?

A: Official regulatory documents focus primarily on interactions with prescription medicines. Publicly available health resources often advise that not enough information is available to fully confirm the safety of using complementary medicines or herbal remedies. Specific guidance on vitamins or supplements is generally not provided in the official labeling, as the focus is on prescription drug interactions.


Q: Are there any known long-term effects of taking Cleosol?

A: Official information indicates that continuous use of Cleosol is generally limited to 2 to 4 consecutive weeks. Treatment duration is limited due to the potential risk of systemic absorption, which can lead to side effects like HPA axis suppression (a decrease in adrenal gland function). Long-term continuous use is typically avoided to manage these risks.


Q: Can Cleosol be taken with pain relievers like ibuprofen or aspirin?

A: Regulatory documents do not commonly report direct drug interactions between topical Cleosol and oral non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. However, official warnings for NSAIDs and corticosteroids primarily pertain to oral (systemic) use, noting an increased risk of gastrointestinal bleeding.


Q: Are there certain lab tests required when taking Cleosol?

A: Due to the potential for systemic absorption, official documents indicate that periodic evaluation for HPA axis suppression may be required during the course of treatment. Monitoring may involve tests to check adrenal gland function, such as the ACTH stimulation test, as described in regulatory information.


Q: Can Cleosol interact with blood pressure medicine?

A: Regulatory information notes that Cleosol is a substrate of the CYP3A4 enzyme. Therefore, some blood pressure medicines (such as certain calcium channel blockers) that inhibit this enzyme can inhibit the metabolism of corticosteroids. This interaction may lead to increased systemic exposure to Cleosol.


Q: Does Cleosol cause weight gain or weight loss?

A: Weight changes are not commonly listed as a general side effect in adults using Cleosol. However, regulatory documents caution that in children, systemic absorption has been associated with effects like delayed weight gain and symptoms related to Cushing's syndrome, which can involve changes in body weight.


Q: What happens if I miss taking Cleosol?

A: Official patient information advises that if an application is missed, you should apply the dose as soon as you remember. If the time for the next scheduled dose is very close, regulatory information advises skipping the missed dose and returning to the normal schedule. Applying two doses at the same time is not recommended.


Q: Are there different strengths of Cleosol available?

A: The active ingredient in Cleosol, clobetasol propionate, is typically formulated at a single concentration of 0.05%. This strength remains consistent across its various forms, such as the cream, ointment, or solution, as noted in the official labeling.


Q: Can Cleosol affect my sleep?

A: While insomnia is generally not listed as a frequent adverse event, official documents identify hypercortisolism (excessive cortisol in the body) as a potential risk from high systemic absorption. This condition, which can occur with potent steroids, can be associated with various sleep disturbances.


Q: Is Cleosol a controlled substance?

A: According to official drug scheduling information from agencies like the Drug Enforcement Administration (DEA), the active ingredient in Cleosol, clobetasol propionate, is not classified as a controlled substance.


Q: Does Cleosol have any warnings related to driving or operating machinery?

A: The official product information, such as the European Summary of Product Characteristics (SmPC), generally states that topical clobetasol propionate has no or very little influence on a person's ability to drive and use heavy machinery.


Q: What are some misunderstandings people have about how Cleosol works?

A: Official regulatory documents provide clear boundaries for the drug's use by explicitly stating conditions for which it is not to be used. These include inflammatory conditions like rosacea or perioral dermatitis. The restrictions help clarify the intended function and limitations of the medication.


Q: Is Cleosol a new drug or has it been around for a long time?

A: The active ingredient in Cleosol has a long history, with its various brand-name formulations having been approved by the FDA over several years, some as far back as the early 2000s or before. Official records categorize it as an established pharmaceutical agent.


Q: Can Cleosol affect mood or cause anxiety?

A: Official labeling lists Nervous System Disorders (such as headache) as a common adverse event. Studies and official information indicate that high systemic absorption of potent corticosteroids can be associated with psychiatric manifestations or secondary mood disorders.


Q: What does the term 'contraindication' mean for Cleosol?

A: The term contraindication in the official documents means the medicine must not be used by a patient if they have a specific condition, such as untreated skin infections or heart failure. This is because using the drug under these circumstances carries risks that outweigh any potential benefit.


Q: Is Cleosol habit-forming?

A: While not explicitly described as 'habit-forming' in the labels, the therapy is limited in duration (e.g., 2 weeks) due to the risk of systemic effects. The limitation in duration is in place to manage the risk of systemic effects, such as HPA axis suppression.


Q: Does Cleosol affect birth control or fertility?

A: Official regulatory information states that there are no data available in humans to evaluate the effect of topical clobetasol propionate on fertility. Furthermore, official labels do not contain specific information regarding the drug's potential effect on the effectiveness of birth control.


Q: Why is Cleosol only available with a prescription?

A: Cleosol is categorized as a Human Prescription Drug due to its classification as a super-high potency medicine. The prescription requirement reflects the need for medical supervision due to the potential risk of serious systemic adverse effects, such as HPA axis suppression or potential cardiac issues, which necessitate patient monitoring.

How should Cleosol be stored and disposed of?

How to Store and Dispose of Cleosol?

Strict adherence to the official storage and disposal requirements is essential for maintaining product quality and safety. The product must be stored at controlled room temperature, typically between 20 C and 25 C. It is mandatory to keep Cleosol in its original container to protect it from light and moisture.

Key Storage Constraints

Constraint Requirement
Temperature Do not freeze or refrigerate
Handling Keep container tightly closed
Safety Keep out of the sight and reach of children
Stability Discard any unused portion after the labeled in-use period (e.g., 28 days)

Official Disposal

Expired or unused Cleosol must be disposed of according to local pharmaceutical waste regulations. Do not dispose of this medicine in household trash or pour it down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cleosol found in:

A-Z Index: